raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:90065

Acquired aneurysmal subarachnoid hemorrhage

Type
Particular clinical situation in a disease or syndrome
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare, life threatening rare neurologic disease characterized by a sudden rupture of an intracranial aneurysm into the subarachnoid space. It usually presents with a sudden, severe, excruciating headache accompanied by nausea, vomiting and syncope. Other features may include focal neurological signs, third and sixth nerve palsies, seizures and cardiac failure. Early complications include rebleeding, hydrocephalus, and seizures.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcquired aneurysmal subarachnoid hemorrhage
frHémorragie subarachnoïdienne par rupture d'anévrisme intracrânien, forme acquise
deAneurysmatische Subarachnoidalblutung, erworbene
esHemorragia subaracnoidea aneurismática adquirida
itEmorragia subaracnoidea aneurismatica acquisita
nlVerworven aneurysmale subarachnoïdale hemorragie
ptHemorragia subaracnóidea aneurismática
plNabyty krwotok podpajęczynówkowy z pkniętego tętniaka
csZískané subarachnoideální krvácení z aneuryzmatu
ukНабутий аневризматичний субарахноїдальний крововилив
zh获得性动脉瘤蛛网膜下腔出血
trEdinsel anevrizmal subaraknoid kanama

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10I60.9NTBTinclusionvalidated
ICD-118B01.0Especificvalidated
MONDO0019543Evalidated
UMLSC0338572Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00010 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2015[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

34 annotations · validated 2020-03-13
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0009145Abnormal cerebral artery morphology
Frequent (79-30%)
HP:0001342Cerebral hemorrhage
HP:0100543Cognitive impairment
HP:0001259Coma
HP:0001133Constriction of peripheral visual field
HP:0002315Headache
HP:0000822Hypertension
HP:0002354Memory impairment
HP:0002018Nausea
HP:0012250ST segment depression
HP:0025637Vasospasm
HP:0002013Vomiting
Occasional (29-5%)
HP:0030955Alcoholism
HP:0002637Cerebral ischemia
HP:0001635Congestive heart failure
HP:0006824Cranial nerve paralysis
HP:0004302Functional motor deficit
HP:0000238Hydrocephalus
HP:0003124Hypercholesterolemia
HP:0003074Hyperglycemia
HP:0031885Hyperglycorrhachia
HP:0000821Hypothyroidism
HP:0031058Impairment of activities of daily living
HP:0002490Increased CSF lactate
HP:0001974Increased total leukocyte count
HP:0002140Ischemic stroke
HP:0001712Left ventricular hypertrophy
HP:0001658Myocardial infarction
HP:0002344Progressive neurologic deterioration
HP:0005184Prolonged QTc interval
HP:0001250Seizure
HP:0001279Syncope
HP:0000505Visual impairment
Very rare (<4-1%)
HP:0040075Hypopituitarism

Run the differential on the 1 obligate / very frequent terms

Annotation source: 30535853[PMID]_24670311[PMID]_29623945[PMID]_27316915[PMID]_31051460[PMID]_30366144[PMID]

7

Sources for this card